Tech
Airgain Q3 Results: Stock Plummets 37% After Revenue Drop
Airgain Inc, a prominent provider of wireless connectivity solutions, announced its financial results for the third quarter (Q3) ended September 30, 2023, triggering a significant...
2U Stock Dips 48.9% on Disappointing Q3 Results
In a recent financial disclosure, 2U, a leading online education platform company, revealed its third-quarter (Q3) results for the period ending September 30, 2023, sending...
Marpai Stock Surges 52% After Restructures in Leadership Team
Marpai, a technology company bringing health plan services to employers that directly pay for employee health benefits, witnessed a surge in its stock on Friday...
Lantern Pharma Q3 Results: Steady Financial Gains, Stock Jumps
Lantern Pharma, a pioneering artificial intelligence (“AI”) company specializing in targeted and transformative cancer therapies, unveiled its financial results for the third quarter (Q3) ending...
JanOne Inc Stock Surges 117% Despite Lack of News
In a surprising turn of events, JanOne Inc, a prominent biotechnology firm specializing in the development of treatments for severe pain conditions, witnessed a notable...
Wearable Devices’ Public Offering Triggers Stock Decline, Eyes $2M Funding Boos
Wearable Devices, a leading technology company specializing in AI-powered touchless sensing wearables, has unveiled details of its upcoming public offering, anticipating gross proceeds of approximately...
WideOpenWest Delivers Solid Q3 Results, Stock Still Falls
WideOpenWest Inc (WOW), a prominent broadband provider, unveiled its financial results for the third quarter (Q3)ending September 30, 2023, on November 8, 2023. The company...
Ikena Oncology Reports Q3 Results and Data from Phase I Clinical Trial, Stock Dips
Ikena Oncology, a pioneering targeted oncology company revolutionizing patient-directed cancer treatment, unveiled its earnings results for the third quarter (Q3) and nine months ending September...
Atara Biotherapeutics’ EMBOLD Study Fails to Meet Primary Endpoint in Multiple Sclerosis Trial, Stock Falls
Atara Biotherapeutics, a leading biotechnology company, witnessed a sharp decline in its stock value today following the release of disappointing results from its Phase 2...
Astra Space Founders Propose Privatization at $30M Valuation, Stock Skyrockets
In a move that sent ripples through the market, the founders of Astra Space Inc. have unveiled plans to take the company private at a...
